[go: up one dir, main page]

ES2153385T3 - Composicion acuosa a base de hormona del crecimiento humana. - Google Patents

Composicion acuosa a base de hormona del crecimiento humana.

Info

Publication number
ES2153385T3
ES2153385T3 ES93918499T ES93918499T ES2153385T3 ES 2153385 T3 ES2153385 T3 ES 2153385T3 ES 93918499 T ES93918499 T ES 93918499T ES 93918499 T ES93918499 T ES 93918499T ES 2153385 T3 ES2153385 T3 ES 2153385T3
Authority
ES
Spain
Prior art keywords
growth hormone
human growth
based composition
hormone based
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93918499T
Other languages
English (en)
Other versions
ES2153385T5 (es
Inventor
Barbara H O'connor
James Q Oeswein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25448638&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2153385(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ES2153385T3 publication Critical patent/ES2153385T3/es
Application granted granted Critical
Publication of ES2153385T5 publication Critical patent/ES2153385T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE PRESENTA UNA FORMULACION ACUOSA FARMACEUTICAMENTE ACEPTABLE QUE CONTIENE UNA HORMONA DE CRECIMIENTO HUMANA, UN TAMPON Y UN SURFACTANTE NO IONICO Y, OPCIONALMENTE, UNA SAL NEUTRA, MANITOL, O, UN CONSERVANTE. TAMBIEN SE PRESENTAN LOS ELEMENTOS ASOCIADOS Y METODOS PARA LA PREPARACION, CONSERVACION Y UTILIZACION DE TALES FORMULACIONES.
ES93918499T 1992-07-31 1993-07-29 Composicion acuosa a base de hormona del crecimiento humana. Expired - Lifetime ES2153385T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92340192A 1992-07-31 1992-07-31
US923401 1992-07-31

Publications (2)

Publication Number Publication Date
ES2153385T3 true ES2153385T3 (es) 2001-03-01
ES2153385T5 ES2153385T5 (es) 2008-09-01

Family

ID=25448638

Family Applications (2)

Application Number Title Priority Date Filing Date
ES99107148T Expired - Lifetime ES2286868T3 (es) 1992-07-31 1993-07-29 Composicion acuosa a base de hormana del crecimiento humana.
ES93918499T Expired - Lifetime ES2153385T5 (es) 1992-07-31 1993-07-29 Composicion acuosa a base de hormona del crecimiento humana.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES99107148T Expired - Lifetime ES2286868T3 (es) 1992-07-31 1993-07-29 Composicion acuosa a base de hormana del crecimiento humana.

Country Status (15)

Country Link
EP (2) EP0955062B1 (es)
JP (2) JP4018133B2 (es)
AT (2) ATE197405T1 (es)
AU (1) AU686567C (es)
CA (3) CA2337745C (es)
DE (2) DE69334134T2 (es)
DK (2) DK0652766T4 (es)
ES (2) ES2286868T3 (es)
GR (1) GR3035144T3 (es)
IL (1) IL106524A (es)
MD (1) MD1699F2 (es)
MX (1) MX9304613A (es)
NZ (1) NZ255158A (es)
PT (1) PT652766E (es)
WO (1) WO1994003198A1 (es)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981485A (en) 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
US5763394A (en) * 1988-04-15 1998-06-09 Genentech, Inc. Human growth hormone aqueous formulation
US6022858A (en) * 1991-12-20 2000-02-08 Novo Nordisk A/S Pharmaceutical formulation of human-growth hormone pretreated with zinc salt
DK204791D0 (da) * 1991-12-20 1991-12-20 Novo Nordisk As Hidtil ukendt farmaceutisk praeparat
US5849704A (en) * 1991-12-20 1998-12-15 Novo Nordisk A/S Pharmaceutical formulation
US5849700A (en) * 1991-12-20 1998-12-15 Novo Nordisk A/S Pharmaceutical formulation
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
SE9201073D0 (sv) * 1992-04-03 1992-04-03 Kabi Pharmacia Ab Protein formulation
US5877016A (en) 1994-03-18 1999-03-02 Genentech, Inc. Human trk receptors and neurotrophic factor inhibitors
DE69420872T2 (de) * 1994-06-17 2000-01-13 Applied Research Systems Ars Holding N.V., Curacao Hgh enthaltende pharmazeutische zubereitungen
US5631225A (en) * 1994-10-13 1997-05-20 Novo Nordisk A/S Pharmaceutical formulation
US5654278A (en) * 1994-10-13 1997-08-05 Novo Nordisk A/S Composition and method comprising growth hormone and leucine
US5547696A (en) * 1994-10-13 1996-08-20 Novo Nordisk A/S Pharmaceutical formulation
US5705482A (en) * 1995-01-13 1998-01-06 Novo Nordisk A/S Pharmaceutical formulation
US5552385A (en) * 1995-06-05 1996-09-03 Novo Nordisk A/S Pharmaceutical formulation
US6790439B1 (en) * 1995-06-07 2004-09-14 Zymogenetics, Inc. Thrombopoietin compositions
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
SE9502927D0 (sv) * 1995-08-24 1995-08-24 Pharmacia Ab Solution containing IGF-I
GB9526733D0 (en) 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
AUPN801296A0 (en) 1996-02-12 1996-03-07 Csl Limited Stabilised growth hormone formulation and method of preparation thereof
US20070179096A1 (en) 1996-04-24 2007-08-02 Novo Nordisk A/S Pharmaceutical Formulation
US20020077461A1 (en) * 1996-04-24 2002-06-20 Soren Bjorn Pharmaceutical formulation
SE9704405D0 (sv) * 1997-11-28 1997-11-28 Pharmacia & Upjohn Ab New syringe
JP3723857B2 (ja) * 1998-02-04 2005-12-07 日本ケミカルリサーチ株式会社 ヒト成長ホルモン含有水性医薬組成物
IL140984A0 (en) * 1998-07-23 2002-02-10 Lilly Co Eli Fsh and fsh variant formulations, products and methods
US20030166525A1 (en) 1998-07-23 2003-09-04 Hoffmann James Arthur FSH Formulation
BR0013162A (pt) * 1999-07-12 2002-05-28 Grandis Biotech Gmbh Formulações de hormÈnio de crescimento
EP1276856A4 (en) 2000-04-12 2004-06-09 Human Genome Sciences Inc ALBUMIN FUSION PROTEINS
US20020061838A1 (en) * 2000-05-17 2002-05-23 Barton Holmquist Peptide pharmaceutical formulations
GB2371227A (en) * 2001-01-10 2002-07-24 Grandis Biotech Gmbh Crystallisation - resistant aqueous growth hormone formulations
US7507413B2 (en) 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
US20080194481A1 (en) 2001-12-21 2008-08-14 Human Genome Sciences, Inc. Albumin Fusion Proteins
AU2002364586A1 (en) 2001-12-21 2003-07-30 Delta Biotechnology Limited Albumin fusion proteins
AR040529A1 (es) * 2002-07-09 2005-04-13 Grandis Biotech Gmbh Formulaciones de hgh en alta concentracion que contienen 1,2-propilenglicol
BR0317888A (pt) 2002-12-31 2005-12-06 Altus Pharmaceuticals Inc Cristais do hormÈnio do crescimento humano e processos para preparação dos mesmos
EP1594530A4 (en) 2003-01-22 2006-10-11 Human Genome Sciences Inc HYBRID PROTEINS OF ALBUMIN
HRP20100727T4 (hr) 2003-04-02 2018-11-16 Ares Trading S.A. Tekući farmaceutski pripravci fsh i lh zajedno s ne-ionskim surfaktantom
PL1638595T3 (pl) 2003-06-20 2013-06-28 Ares Trading Sa Liofilizowane formulacje FSH/LH
ATE554792T1 (de) * 2003-12-23 2012-05-15 Pharmacia Corp Stabiles wachstumshormon-flüssigformulierung
CN102816241B (zh) 2004-02-09 2015-07-22 人类基因科学公司 清蛋白融合蛋白
WO2005105148A2 (en) 2004-04-07 2005-11-10 Ares Trading S.A.- Liquid growth hormone formulation
AU2007258609B2 (en) 2006-06-07 2013-01-24 Human Genome Sciences, Inc. Albumin fusion proteins
US8409586B2 (en) 2006-07-06 2013-04-02 Daewoong Co., Ltd. Stable liquid formulation of human growth hormone
CA2672284C (en) * 2006-12-18 2014-08-26 Altus Pharmaceuticals Inc. Human growth hormone formulations
EP2449114B9 (en) 2009-07-01 2017-04-19 Protiva Biotherapeutics Inc. Novel lipid formulations for delivery of therapeutic agents to solid tumors
EP2501367B1 (en) * 2009-11-17 2015-01-21 Ipsen Pharma S.A.S. Formulation for HGH and RHIGF-1 combination
AU2011208625C1 (en) 2010-01-22 2022-08-18 Novo Nordisk Health Care Ag Growth hormones with prolonged in-vivo efficacy
CA2787895A1 (en) 2010-01-22 2011-07-28 Novo Nordisk Health Care Ag Stable growth hormone compounds
WO2012000104A1 (en) 2010-06-30 2012-01-05 Protiva Biotherapeutics, Inc. Non-liposomal systems for nucleic acid delivery
KR101337797B1 (ko) * 2010-07-14 2013-12-06 한미사이언스 주식회사 지속형 인간 성장 호르몬 결합체 액상 제제
WO2013014196A1 (en) * 2011-07-25 2013-01-31 Sandoz Ag Aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein
US10064951B2 (en) * 2012-03-30 2018-09-04 Hanmi Science Co., Ltd. Liquid formulation of highly concentrated long-acting human growth hormone conjugate
JP5487276B2 (ja) * 2012-11-12 2014-05-07 デウン カンパニー，リミテッド ヒト成長ホルモンを含有する安定した液状製剤
WO2014166836A1 (en) * 2013-04-05 2014-10-16 Novo Nordisk A/S Growth hormone compound formulation
CN113425835B (zh) * 2020-03-23 2024-03-19 常州健益生物制药有限公司 一种生长激素原料药溶液、水针剂及其制备方法
CN112494638B (zh) * 2020-12-22 2023-12-19 深圳科兴药业有限公司 一种人生长激素注射剂组合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783441A (en) * 1979-04-30 1988-11-08 Hoechst Aktiengesellschaft Aqueous protein solutions stable to denaturation
DE3325223A1 (de) * 1983-07-13 1985-01-24 Hoechst Ag, 6230 Frankfurt Gegen denaturierung bestaendige, waessrige proteinloesungen, verfahren zu ihrer herstellung und ihre verwendung
IL79552A0 (en) * 1985-07-30 1986-10-31 Int Minerals & Chem Corp Stabilization of growth promoting hormones
ES2044941T5 (es) * 1987-08-21 1999-02-16 Mallinckrodt Group Inc Estabilizador de hormonas promotoras del crecimiento.
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
US4904043A (en) * 1988-06-15 1990-02-27 American Telephone And Telegraph Company, At&T Bell Laboratories Optical data link dual wavelength coupler
US5182258A (en) * 1989-03-20 1993-01-26 Orbon Corporation Systemic delivery of polypeptides through the eye
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
US5210017A (en) * 1990-11-19 1993-05-11 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method

Also Published As

Publication number Publication date
CA2489978A1 (en) 1994-02-17
ATE359824T1 (de) 2007-05-15
EP0955062A1 (en) 1999-11-10
CA2337745C (en) 2005-04-12
DE69329651T2 (de) 2001-05-23
EP0652766A1 (en) 1995-05-17
CA2139358A1 (en) 1994-02-17
ES2286868T3 (es) 2007-12-01
AU686567C (en) 2002-08-08
DE69334134D1 (de) 2007-05-31
DK0652766T3 (da) 2001-01-29
IL106524A0 (en) 1993-11-15
DK0652766T4 (da) 2008-06-09
AU4792793A (en) 1994-03-03
DE69329651D1 (de) 2000-12-14
NZ255158A (en) 1997-09-22
EP0652766B2 (en) 2008-03-19
ATE197405T1 (de) 2000-11-11
JP4018133B2 (ja) 2007-12-05
MD1699F2 (ro) 2001-07-31
MD960246A (en) 1998-01-31
EP0652766B1 (en) 2000-11-08
JP2007045841A (ja) 2007-02-22
IL106524A (en) 2000-08-31
JPH07509719A (ja) 1995-10-26
AU686567B2 (en) 1998-02-12
PT652766E (pt) 2001-04-30
CA2139358C (en) 2001-02-13
DE69334134T2 (de) 2007-12-20
DK0955062T3 (da) 2007-09-17
WO1994003198A1 (en) 1994-02-17
MX9304613A (es) 1994-03-31
DE69329651T3 (de) 2008-10-30
EP0955062B1 (en) 2007-04-18
CA2337745A1 (en) 1994-02-17
GR3035144T3 (en) 2001-04-30
ES2153385T5 (es) 2008-09-01

Similar Documents

Publication Publication Date Title
ES2153385T3 (es) Composicion acuosa a base de hormona del crecimiento humana.
DK0395329T3 (da) Sammensætning i form af et skum indeholdende 5-aminosalicylsyre til intrarektal administration
HUT62201A (en) Method for producing galen preparations containing cyclosporines as active ingredient
TW360494B (en) Parasiticide formulations suitable for dermal application
PT2130554E (pt) Formulações de factor viii isentas de albumina
FI933393A0 (fi) Agglomererade hydrofila komplex med flerfasiga frigoeringsegenskaper
PL329386A1 (en) Growth hormone, amino acid and non-ionic detergent containing pharmaceutic
EP0497258A3 (en) Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer
NO910868D0 (no) Antiglaukompreparater inneholdende 3-arylkarbonyl-1-aminoalkyl-1h-indol og fremgangsmaate for fremstilling derav.
DK0395287T3 (da) Tandbehandlingspræparater
IT1284604B1 (it) Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva
CA2063273A1 (en) Surfactant compositions and methods
IE802033L (en) Dibenzazepine derivatives
ATE238063T1 (de) Wässrige zusammensetzung mit verzögerter freisetzung, enthaltend rinderwachstumshormon- freisetzungsfaktor
ES2139769T3 (es) Uso de azoles como agentes viricidas en soluciones de proteinas biologicamente activas.
DK248987D0 (da) Farmaceutiske praeparater til forbedring af sammensaetningen af lipider i blod
GB2021581A (en) Stabilisation of PGl2 derivatives
IT1283324B1 (it) Composizioni veterinarie a base di antibatterici per uso intramammario
SE8400971L (sv) Profylaktiskt och lekande medel for arterioskleros
GR3018349T3 (en) Use of naproxen as mydriatic agent.
CA2066945A1 (en) Oral, cutaneous and intravaginal pharmaceutical compositions in the form of foam
ITMI920760U1 (it) Struttura di utensile del tipo fresca o simile particolarmente per l'esecuzione di interventi chirurgici di implantollogia odontoiatrica

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 652766

Country of ref document: ES